Guggenheim Capital’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-18,715
Closed -$263K 2036
2022
Q2
$263K Sell
18,715
-2,007
-10% -$28.6K ﹤0.01% 1839
2022
Q1
$297K Sell
20,722
-85
-0.4% -$1.25K ﹤0.01% 1889
2021
Q4
$284K Sell
20,807
-2,224
-10% -$31.2K ﹤0.01% 1896
2021
Q3
$377K Buy
23,031
+2,131
+10% +$35.8K ﹤0.01% 1852
2021
Q2
$352K Buy
+20,900
New +$356K ﹤0.01% 1963
2020
Q4
Sell
-10,534
Closed -$188K 2114
2020
Q3
$188K Sell
10,534
-1,229
-10% -$22.4K ﹤0.01% 1803
2020
Q2
$211K Sell
11,763
-3,846
-25% -$69K ﹤0.01% 1728
2020
Q1
$237K Buy
15,609
+2,127
+16% +$38.6K ﹤0.01% 1613
2019
Q4
$266K Buy
13,482
+1,496
+12% +$28.6K ﹤0.01% 1888
2019
Q3
$206K Buy
+11,986
New +$207K ﹤0.01% 1998

Other funds holding TAK